NCT05087849View on ClinicalTrials.gov

Intralesional HPV Vaccine for Condylomata

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Human Papilloma VirusWartsWarts, GenitalCondylomaCondylomata Acuminata
Interventions
BIOLOGICAL

nonavalent human papillomavirus vaccine

Intralesional injection of nonavalent human papillomavirus vaccine (Gardasil 9) at 0 and 4 weeks

Trial Locations (1)

94110

Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER